Propofol suppresses the sleep state-dependent P13 midlatency auditory evoked potential in the rat

Brain Research Bulletin

Volumn 61, Issue 2, 2003, Pages 189-196

  Homma, Yuko ^a   Teneud, Luis ^a,b   Skinner, Robert D ^a   Williams, Keith ^a   Garcia Rill, Edgar ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSIDAD DE LOS ANDES   (Venezuela)

Author keywords

Arousal; Auditory evoked potentials; P13 potential; Pedunculopontine nucleus; Propofol; Reticular activating system

Indexed keywords

ANESTHETIC AGENT; PROPOFOL;

ANIMAL EXPERIMENT; AROUSAL; ARTICLE; CENTRAL NERVOUS SYSTEM FUNCTION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DISTRACTIBILITY; DOSE CALCULATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; EVOKED AUDITORY RESPONSE; HABITUATION; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETICULAR FORMATION; SLEEP;

EID: 0038721962     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(03)00116-3     Document Type: Article

References (59)

1. Andrade J., Sapsford D.J., Jeevaratnum D., Pickford A.J., Jones J.G. The coherent frequency in the electroencephalogram as an objective measure of cognitive function during propofol sedation. Anesth. Analg. 83:1996;1279-1284.
2. Barann M., Goethert M., Fink K., Boenisch H. Inhibition by anaesthetics of 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of NlE-115 neuroblastoma cells. Naunyn Schmiedebergs Arch. Pharmacol. 347:1993;125-132.
3. Baum V.C. Distinctive effects of three intravenous anesthetics on the inward rectifier (IK1) potassium currents in myocardium: implications for the mechanism of action. Anesth. Analg. 76:1993;18-23.
4. Bickford-Wymer P.C., Nagamoto H., Johnson R., Adler L.E., Egan M., Rose G.M., Freedman R. Auditory sensory gating in hippocampal neurons: a model system in the rat. Biol. Psychiatry. 27:1990;183-192.
5. Boop F.A., Garcia-Rill E., Dykman R., Skinner R.D. The P1: insights into attention and arousal. Pediatr. Neurosurg. 20:1994;57-62.
6. Buchwald J.S., Erwin R.J., Van Lancker D., Cummings J.L. Midlatency auditory evoked responses: differential abnormality of P1 in Alzheimer's disease. Electroencephalogr. Clin. Neurophysiol. 74:1989;378-384.
7. Buchwald J.S., Erwin R.J., Van Lancker D., Guthrie D., Schwafel J., Tanguay P. Midlatency auditory evoked responses: P1 abnormalities in adult autistic subjects. Electroencephalogr. Clin. Neurophysiol. 84:1992;164-171.
8. Buchwald J.S., Rubinstein E.H., Schwafel J., Strandburg R.J. Midlatency auditory evoked responses: differential effects of a cholinergic agonist and antagonist. Electroencephalogr. Clin. Neurophysiol. 80:1991;303-309.
9. Campbell K.A., Kalmbacher C.E., Specht C.D., Gregg T.R. Dependence of rat vertex evoked potentials on central muscarinic receptor activation. Brain Res. 702:1995;110-116.
10. Clothier J., Scruggs J.T., Gamble L.J., Skinner R.D., Garcia-Rill E. The P1/P50 midlatency auditory evoked potential in depression. Sleep. 21:1998;224.
11. Collins G.G. Effects of the anaesthetic 2,6-diisopropylphenol on synaptic transmission in the rat olfactory cortex slice. Br. J. Pharmacol. 95:1988;939-949.
12. Concas A., Santoro G., Serra M., Sanna E., Biggio G. Neurochemical action of the general anaesthetic propofol on the chloride ion channel coupled with the GABAA receptors. Brain Res. 542:1991;225-232.
13. Dilger J.P., Vidal A.M., Mody H.I., Liu Y. Evidence for direct actions of general anesthetics on an ion channel protein: a new look at a unified mechanism of action. Anaesthesia. 81:1994;431-442.
14. Engeland C.G., Vanderwolf C.H., Gelb A.W. Rats show unimpaired learning within minutes after recovery from single bolus propofol anesthesia. Can. J. Anaesth. 46:1999;586-592.
15. Erwin R.J., Buchwald J.S. Midlatency auditory evoked responses: differential effects of sleep in the human. Electroencephalogr. Clin. Neurophysiol. 65:1986;383-392.
16. Erwin R.J., Buchwald J.S. Midlatency auditory evoked responses: differential recovery cycle characteristics. Electroencephalogr. Clin. Neurophysiol. 64:1986;417-423.
17. R.J. Erwin, J.S. Buchwald, Midlatency auditory evoked responses in the human and in the cat model, in: R. Johnson, J.W. Rohrbaugh, R. Parasweraman (Eds.), Current Trends in Event-Related Potential Research, Elsevier, Amsterdam, 1987, pp. 461-467.
18. Freedman R., Adler L.E., Waldo M.C., Pachtman E., Franks R.D. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biol. Psychiatry. 18:1983;537-551.
19. Frenkel C., Urban B.W. Human brain sodium channels as one of the molecular target sites for the new intravenous anaesthetic propofol (2,6-diisopropylphenol). Eur. J. Pharmacol. 208:1991;75-79.
20. Garcia-Rill E. Disorders of the reticular activating system. Med. Hypotheses. 49:1997;379-387.
21. E. Garcia-Rill, R.D. Skinner, The sleep state-dependent P50 midlatency auditory evoked potential, in: T.L. Lee-Chiong, M.A. Carskadon, M.J. Sateia (Eds.), Sleep Medicine, Hanley & Belfus, Philadelphia, 2001, pp. 697-704.
22. Haberham Z.l., van den Brom W.E., Venker-van Haagen A.J., de Groot H.N.M., Baumans V., Hellebrekers L.J. The rat vertex-middle latency auditory-evoked potential as indicator of anaesthetic depth: a comparison with evoked-reflex testing. Brain Res. 873:2000;287-290.
23. Hales T.G., Lambert J.J. The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones. Br. J. Pharmacol. 104:1991;619-628.
24. Hara H., Kai Y., Ikemoto Y. Enhancement by propofol of the gamma-aminobutyric acid. A response in dissociated hippocampal pyramidal neurons in the rat. Anaesthesia. 81:1994;988-994.
25. Harrison J.B., Woolf N.J., Buchwald J.S. Cholinergic neurons of the feline pontomesencephalon. I. Essential role in "Wave A" generation. Brain Res. 520:1990;43-54.
26. Hinman C.L., Buchwald J.S. Depth evoked potential and single unit correlates of vertex midlatency auditory evoked responses. Brain Res. 264:1983;57-67.
27. Kubota T., Hirota K., Yoshida H., Takahashi S., Anzawa N., Ohkawa H., Kushikata N., Matsuki A. Effects of sedatives on noradrenaline release from the medial prefrontal cortex in rats. Psychopharmacology. 146:1999;335-338.
28. Kushikata T., Hirota K., Yoshida H., Kubota T., Ishihara H., Matsuki A. Alpha-2 adrenoreceptor activity affects propofol-induced sleep time. Anesth. Analg. 94:2002;1201-1206.
29. Liu W.D.H., Thorp T.A.S., Graham S.G., Aitkenhead A.R. Incidence of awareness with recall during general anaesthesia. Anaesthesia. 46:1991;435-437.
30. Luntz-Leybman V., Bickford P.C., Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 587:1992;130-136.
31. Lydic R. Pain: a bridge linking anesthesiology and sleep research. Sleep. 24:2001;1-3.
32. R. Lydic, H.A. Baghdoyan, Opioids, sedation and sleep. Different states, similar traits, and the search for common mechanisms, in: S. Malviya, N. Naughton, K.K. Tremper (Eds.), Contemporary Clinical Neuroscience: Sedation and Analgesia for Diagnostic and Therapeutic Procedures, Humanae Press, Totowa, NJ, 2003, pp. 1-31.
33. Mantzardis H., Kenny G.N.C. Auditory evoked potential index: a quantitative measure of changes in auditory evoked potentials during general anaesthesia. Anaesthesia. 52:1997;1030-1036.
34. Mascia M.P., Mihic S.J., Valenzuela C.F., Schofield P.R., Harris R.A. A single amino acid determines differences in ethanol actions on strychnine-sensitive glycine receptors. Mol. Pharmacol. 50:1996;402-406.
35. Mason S.T., King R.A.J., Banks P., Angel A. Brain noradrenaline and anesthesia: behavioural and electrophysiological evidence. Neuroscience. 10:1993;177-185.
36. Miyazato H., Skinner R.D., Cobb M., Andersen B., Garcia-Rill E. Midlatency auditory evoked potentials in the rat - effects of interventions which modulate arousal. Brain Res. Bull. 48:1999;545-553.
37. Miyazato H., Skinner R.D., Crews T., Williams K., Garcia-Rill E. Serotonergic modulation of the P13 midlatency auditory evoked potential in the rat. Brain Res. Bull. 51:2000;387-391.
38. Miyazato H., Skinner R.D., Garcia-Rill E. Sensory gating of the P13 midlatency auditory evoked potential and the startle response in the rat. Brain Res. 822:1999;60-71.
39. Miyazato H., Skinner R.D., Garcia-Rill E. Neurochemical modulation of the P13 midlatency auditory evoked potential in the rat. Neuroscience. 92:1999;911-920.
40. Miyazato H., Skinner R.D., Garcia-Rill E., Reese N.B., Hendricks B. The rat P1 auditory middle latency potential. Neurosci. Abst. 19:1993;1422.
41. Miyazato H., Skinner R.D., Reese N.B., Boop F.A., Garcia-Rill E. A middle-latency auditory-evoked potential in the rat. Brain Res. Bull. 37:1995;247-255.
42. Miyazato H., Skinner R.D., Reese N.B., Mukawa J., Garcia-Rill E. Midlatency auditory evoked potentials and the startle response in the rat. Neuroscience. 75:1996;289-300.
43. Orser B.A., Bertlik M., Wang L.Y., MacDonald J.F. Inhibition by propofol (2,6-diisopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br. J. Pharmacol. 116:1995;1761-1768.
44. Peduto V.A., Concas A., Santoro G., Biggio G., Gessa G.L. Biochemical and electrophysiologic evidence that propofol enhances GABAergic transmission in the rat brain. Anaesthesia. 75:1991;1000-1009.
45. Ratnakumari L., Hemmings H.C. Effects of propofol on sodium channel-dependent sodium influx and glutamate release in rat cerebrocortical synaptosomes. Anaesthesia. 86:1997;428-439.
46. Reese N.B., Garcia-Rill E., Skinner R.D. The pedunculopontine nucleus auditory input, arousal and pathophysiology. Prog. Neurobiol. 42:1995;102-133.
47. Reese N.B., Garcia-Rill E., Skinner R.D. Auditory input to the pedunculopontine nucleus: I. Evoked potentials. Brain Res. Bull. 37:1995;257-264.
48. Reese N.B., Garcia-Rill E., Skinner R.D. Auditory input to the pedunculopontine nucleus: II. Unit responses. Brain Res. Bull. 37:1995;265-273.
49. Rehberg B., Duch D.S. Suppression of central nervous system sodium channels by propofol. Anesthesia. 91:1999;512-520.
50. Schwender D., Daunderer M., Mulzer S., Klasing S., Finsterer U., Peter K. Midlatency auditory evoked potentials predict movements during anesthesia with isoflurane or propofol. Anesth. Analg. 85:1997;164-173.
51. Simpson G.V., Knight R.T. Multiple brain systems generating the rat auditory evoked potential. II. Dissociation of auditory cortex and non-lemniscal generator systems. Brain Res. 602:1991;251-263.
52. Simpson V.J., Blednov Y. Propofol produces differences in behavior but not chloride channel function between selected lines of mice. Anesth. Analg. 82:1996;327-331.
53. Skinner R.D., Rasco L., Fitzgerald J., Karson C.N., Matthew M., Williams K., Garcia-Rill E. Reduced sensory gating of the P1 potential in rape victims and combat veterans with posttraumatic stress disorder. Depress. Anxiety. 9:1999;122-130.
54. Stevens K.E., Fuller L.L., Rose G.M. Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating. Brain Res. 555:1991;91-98.
55. Stevens K.E., Meltzer J., Rose G.M. Disruption of sensory gating by the alpha-2 selective noradrenergic antagonist yohimbine. Biol. Psychiatry. 33:1993;130-132.
56. Teneud L., Miyazato H., Skinner R.D., Garcia-Rill E. Cholinergic modulation of the sleep state-dependent P13 midlatency auditory evoked potential in the rat. Brain Res. 884:2000;196-200.
57. Thornton C., Konieczko K.M., Knight A.B., Kaul B., Jones J.G., Dore J.C., White D.C. Effect of propofol on the auditory evoked response and oesophageal contractility. Br. J. Anaesth. 63:1989;411-417.
58. Xuan Y.K., Glass P.S.A. Propofol regulation of calcium entry pathways in cultured A10 and rat aortic smooth muscle cell lines. Br. J. Pharmacol. 117:1996;5-12.
59. Yamakura T., Sakimura K., Shimoji K., Mishina M. Effects of propofol on various AMPA-, kainate-, and NMDA-selective glutamate receptor channels expressed in Xenopus oocytes. Neurosci. Lett. 188:1995;187-190.